Cargando…
Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013
PURPOSE: Human epidermal growth factor receptor 2 (HER2)-positive luminal B type comprises estrogen receptor (ER)-positive and HER2-positive cancers, and HER2-negative luminal B type comprises ER-positive cancers showing a Ki-67 labeling index ≥14% or progesterone receptor (PR) expression of <20%...
Autores principales: | Ahn, Hyo Jung, Jung, Soo Jin, Kim, Tae Hyun, Oh, Min Kyung, Yoon, Hye-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490264/ https://www.ncbi.nlm.nih.gov/pubmed/26155291 http://dx.doi.org/10.4048/jbc.2015.18.2.149 |
Ejemplares similares
-
Primary therapy of early breast cancer: Egyptian view of 2021 St. Gallen consensus
por: Khaled, Hussein, et al.
Publicado: (2022) -
St.Gallen consensus on safe implementation of transanal total mesorectal excision
por: Adamina, Michel, et al.
Publicado: (2017) -
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
por: Goldhirsch, A., et al.
Publicado: (2013) -
Customizing early breast cancer therapies – The 2021 St. Gallen International Breast Cancer Consensus Conference()
por: Gnant, Michael, et al.
Publicado: (2022) -
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
por: Goldhirsch, A., et al.
Publicado: (2009)